Immune thrombocytopenia (ITP), once known as immune thrombocytopenic purpura or idiopathic thrombocytopenic purpura, is an immune-mediated acquired disease characterized by a transient or persistent decrease of the platelet count and increased risk of bleeding. 1 Clinical definitions and terminology had once been varied greatly in different clinical studies on ITP, making it very difficult to compare different studies and to share data and clinical experiences. 2 To address these issues, primary ITP was defined as an autoimmune disorder characterized by isolated thrombocytopenia (peripheral blood platelet count <100 × 10 9 /L